Disease Info Card

Hypoalphalipoproteinemia, Familial

Information about Hypoalphalipoproteinemia, Familial: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hypoalphalipoproteinemia, Familial

Most recent studies have shown that Hypoalphalipoproteinemia, Familial shares some biological mechanisms with arteriosclerosis, atherosclerosis, cardiovascular-diseases, coronary-artery-disease, coronary-heart-disease, diabetes-mellitus, diabetes-mellitus-non-insulin-dependent, disorder-of-eye, dyslipidemias, fish-eye-disease, headache, heart-diseases, hereditary-diseases, hypercholesterolemia, hyperlipidemia, hyperlipidemia-familial-combined, hypolipoproteinemias, infarction, myocardial-infarction, tangier-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hypoalphalipoproteinemia, Familial, and have been seen in publications frequently: Cholesterol Efflux, Cholesterol Esterification, Cholesterol Transport, Dna Amplification, Excretion, Immune Response, Innate Immune Response, Lipid Homeostasis, Lipid Transport, Localization, Pathogenesis, Reverse Cholesterol Transport, Secretion, Transport, Vasodilation

Quite a number of genes have been found to play important roles in Hypoalphalipoproteinemia, Familial, such as ABCA1, ABCA4, ABCB6, APOA1, APOC3, ATP6V0A1, CETP, CRP, LCAT, LPA, LPL, RFC1, RFC2, RFC4, SEPSECS, ST8SIA4, TG. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.